Innovax® ILT is a live recombinant vaccine containing Herpesvirus
Turkey (HVT) strain FC-126 expressing glycoproteins D and I (gD and
gI) from Infectious Laryngotracheitis virus (ILT) strain
USDA Challenge Lot No. 83-2. HVT virus induces immunity against
Marek's Disease (MD), and gD and gI from ILT virus induce immunity
against ILT virus. Thus, the recombinant viral vaccine Innovax® ILT
gives protection against both Marek's and ILT disease.